What can we learn from β-cell failure biomarker application in diabetes in childhood? A systematic review

doi:10.4239/wjd.v12.i8.1325

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5482)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

374

WORD

HTML

2720

Figures (1-3)

242

Tables (1-3)

297

Sum=3718

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

663

Download

1101

Sum=1764

Aug 15, 2021 (publication date) through Feb 14, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Diabetes. Aug 15, 2021; 12(8): 1325-1362
Published online Aug 15, 2021. doi: 10.4239/wjd.v12.i8.1325

Full Size Figure Download Figure

Figure 3 Diagnostic methods found in the articles included for this review. The methods are ordered from the most used to the least used. The enzyme-linked immunosorbent assay was the most commonly used method; a total of 8 articles used it as a diagnostic method. ELISA: Enzyme-linked immunosorbent assay; qt-PCR: Quantitative polymerase chain reaction.

Citation: Calderón-Hernández MF, Altamirano-Bustamante NF, Revilla-Monsalve C, Mosquera-Andrade MB, Altamirano-Bustamante MM. What can we learn from β-cell failure biomarker application in diabetes in childhood? A systematic review. World J Diabetes 2021; 12(8): 1325-1362
URL: https://www.wjgnet.com/1948-9358/full/v12/i8/1325.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i8.1325